# Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy

> **NCT06302608** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Xiamen Ophthalmology Center Affiliated to Xiamen University** · enrollment: 6 (estimated)

## Conditions studied

- Bietti's Crystalline Dystrophy

## Interventions

- **GENETIC:** NGGT001

## Key facts

- **NCT ID:** NCT06302608
- **Lead sponsor:** Xiamen Ophthalmology Center Affiliated to Xiamen University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-08
- **Primary completion:** 2024-05-29
- **Final completion:** 2028-05-29
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06302608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06302608, "Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06302608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*